» Authors » Hyeon Gyu Yi

Hyeon Gyu Yi

Explore the profile of Hyeon Gyu Yi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 326
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen L, Pham G, Vu P, Yi H
Ann Med Surg (Lond) . 2023 Dec; 85(12):6274-6278. PMID: 38098600
Introduction And Importance: Histiocytic sarcoma (HS) is an extremely rare malignancy in which there has been no standard treatment approach. Some preclinical studies have provided rationales for the application of...
2.
Jung K, Kim Y, Kim Y, Park S, Kim H, Kim S, et al.
Clin Lymphoma Myeloma Leuk . 2019 Aug; 19(10):656-664. PMID: 31375393
Introduction: Decitabine has shown clinical benefits in patients with intermediate (INT)-2 or high-risk myelodysplastic syndrome (MDS), determined according to the International Prognostic Scoring System (IPSS), but the benefits have not...
3.
Lee G, Park S, Go S, Kim H, Kim M, Min C, et al.
Acta Haematol . 2018 Sep; 140(3):146-156. PMID: 30253397
Background: The neutrophil-to-lymphocyte ratio (NLR) is an independent prognostic marker in solid and hematological cancers. While the derived NLR (dNLR) was shown to be non-inferior to the NLR in large...
4.
Kim W, Bae J, Lim J, Lee M, Hahm B, Yi H
Psychooncology . 2017 Sep; 27(3):824-830. PMID: 28857342
Objective: This study was performed to identify relationships between physicians' perceived stigma toward depression and psycho-oncology service utilization on an oncology/hematology ward. Methods: The study participants were 235 patients in...
5.
Kim M, Kim K, Min C, Kwak J, Bae S, Yoon S, et al.
Oncotarget . 2017 Apr; 8(23):37605-37618. PMID: 28402945
Bortezomib-melphalan-prednisone (VMP) showed superior efficacy versus MP as first-line treatment for transplantation-ineligible multiple myeloma (MM). This study investigated the efficacy of VMP for Korean patients with MM.Overall, 177 MM patients...
6.
Yoo S, Koh Y, Kim D, Lee J, Lee J, Lee K, et al.
Ann Hematol . 2017 Jan; 96(4):605-615. PMID: 28091736
Little is known about the characteristics that make patients with acute leukemia suitable for undergoing salvage therapy by allogeneic hematopoietic stem cell transplantation (allo-HSCT). Here, we analyzed the clinical outcomes...
7.
Park Y, Yi H, Lee M, Kim C, Lim J
Acta Haematol . 2017 Jan; 137(2):76-85. PMID: 28076862
Background: The Advanced Lung Cancer Inflammation Index (ALI, body mass index × albumin/neutrophil-to-lymphocyte ratio) has been demonstrated to be a prognostic factor of survival in some solid cancers. We retrospectively...
8.
Choi W, Kim J, Choi S, Park J, Park Y, Lim J, et al.
Clin Imaging . 2016 May; 40(5):837-9. PMID: 27179155
Peritoneal lymphomatosis is a very rare disease of extranodal involvement of malignant lymphoma that is occasionally confounded with other peritoneal diseases. Herein, we reported the case of a 59-year-old woman...
9.
Park Y, Lim J, Yi H, Lee M, Kim C
Turk J Haematol . 2016 Apr; PMID: 27094950
Materials And Methods: From January 2005 to June 2014, among the 69 patients underwent Allo-SCT in our institution, the patients who experienced BKV-HC were investigated retrospectively. Results: Hemorrhagic cystitis (HC)...
10.
Park Y, Lim J, Yi H, Lee M, Kim C
J Korean Med Sci . 2016 Feb; 31(2):208-13. PMID: 26839474
Due to rarity of factor V (FV) deficiency, there have been only a few case reports in Korea. We retrospectively analysed the clinical-laboratory features of FV deficiency in 10 Korean...